

Serum Institute of India Enters Global Effort for New TB Vaccine: Partnership Aims to Produce First New TB Shot in Over a Century
Serum Institute of India (SII) has taken a significant step in the global fight against tuberculosis by partnering to manufacture M72/AS01E, a promising vaccine candidate that could become the first new TB vaccine in more than 100 years. The Pune-based company announced the agreement with the Gates Medical Research Institute (Gates MRI), marking an important milestone in efforts to address one of the world’s most persistent infectious diseases. India’s Serum Institute joins g
MGMMTeam
1 minute ago2 min read
















